CIK 0001725160 · Non-accelerated filer<br>Smaller reporting company
Zentalis Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ZNTL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 823607803
- Phone
- (858) 263-4333
- Business address
- 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA, 92121
- Former names
- Zentalis Pharmaceuticals, LLC, Zeno Pharma, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-17 | Gallagher Cam President | Sale | −9,500 | $24.11 | $229K | 352,511 |
| 2023-01-17 | Gallagher Cam President | Sale | −500 | $24.87 | $12K | 352,011 |
| 2023-01-05 | Gallagher Cam President | Sale | −9,700 | $21.01 | $204K | 362,311 |
| 2023-01-05 | Gallagher Cam President | Sale | −300 | $21.46 | $6K | 362,011 |
| 2022-11-15 | Gallagher Cam President | Sale | −11,600 | $22.72 | $264K | 372,911 |
| 2022-11-15 | Gallagher Cam President | Sale | −900 | $23.48 | $21K | 372,011 |
| 2022-11-09 | Bunker Kevin D. Chief Scientific Officer | Gift | −30,000 | 784,110 | ||
| 2022-11-08 | Gallagher Cam President | Sale | −12,374 | $23.56 | $292K | 384,511 |
| 2022-11-07 | Gallagher Cam President | Sale | −12,343 | $23.66 | $292K | 397,042 |
| 2022-11-07 | Gallagher Cam President | Sale | −157 | $24.24 | $4K | 396,885 |
| 2022-10-17 | Gallagher Cam President | Sale | −12,500 | $23.51 | $294K | 409,385 |
| 2022-10-06 | Gallagher Cam President | Sale | −10,000 | $22.62 | $226K | 421,885 |
| 2022-10-05 | Gallagher Cam President | Sale | −7,004 | $21.92 | $154K | 437,381 |
| 2022-10-05 | Gallagher Cam President | Sale | −5,496 | $22.83 | $125K | 431,885 |
| 2022-10-03 | Epperly Melissa B, Chief Financial Officer | Grant or award | +50,000 | 297,543 | ||
| 2022-10-03 | Bunker Kevin D. Chief Scientific Officer | Grant or award | +50,000 | 814,110 | ||
| 2022-10-03 | Bunker Kevin D. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-10-03 | Brownstein Carrie Chief Medical Officer | Grant or award | +100,000 | 100,000 | ||
| 2022-10-03 | Brownstein Carrie Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2022-10-03 | Brownstein Carrie Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 |
Page 7 of 8 · 160 trades